CAT
Caterpillar Inc.
CAT has the edge over RGR overall, supported by stronger valuation and stronger modeled upside.
RGR
Sturm, Ruger & Company, Inc.
RGR trails on the overall score without a compensating advantage in the available component scores.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RGR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
RGR's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over RGR in the historical PE scenario, which offers more potential upside but is not a forecast.
RGR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.9x | $8.97 | -82% |
| Fair | 17x | $17.19 | -65% |
| Expensive | 31x | $31.06 | -37% |
| Current | 49x | $49.46 | — |
Historical ranges are pointers, not guarantees.
RGR's PE is in its expensive range at 49x.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
RGR Forward outlook
There aren't enough analyst estimates for RGR to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over RGR on earnings, with more consistent year-over-year improvement.
RGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.01 | +677% |
| Q2 2026 | $0.75 | +142% |
| Q1 2026 | -$0.73 | -140% |
| Q4 2025 | -$0.28 | -116% |
| Q3 2025 | $0.13 | -92% |
| Q2 2025 | $0.31 | -83% |
| Q1 2025 | $1.83 | -21% |
| Q4 2024 | $1.77 | -35% |
RGR's earnings per share have fallen from their peak: $1.01 over the past year, against $8.78 in late 2021.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over RGR on profitability, with a higher operating margin.
RGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $147.6M | +16% |
| Q2 2026 | $158.1M | +19% |
| Q1 2026 | $141.4M | +4.1% |
| Q4 2025 | $151.1M | +3.6% |
| Q3 2025 | $126.8M | +3.7% |
| Q2 2025 | $132.5M | +1.3% |
| Q1 2025 | $135.7M | -0.8% |
| Q4 2024 | $145.8M | +12% |
RGR's revenue is recovering but still below its 2021 peak: $148M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +6.8 points |
| Q2 2026 | 4.8% | +21 points |
| Q1 2026 | -1.4% | -7.6 points |
| Q4 2025 | 2.3% | -5.6 points |
| Q3 2025 | -2.8% | -5.8 points |
| Q2 2025 | -16% | -23 points |
| Q1 2025 | 6.2% | +0.7 points |
| Q4 2024 | 7.8% | -0.1 points |
RGR's operating margin was 4% last quarter, up 6.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
RGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.7M | -282% |
| Q2 2026 | $14.1M | +54% |
| Q1 2026 | $14M | +39% |
| Q4 2025 | $12.3M | -25% |
| Q3 2025 | $7M | +168% |
| Q2 2025 | $9.1M | -9.9% |
| Q1 2025 | $10M | +80% |
| Q4 2024 | $16.4M | +32% |
RGR has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over RGR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
RGR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +25.2K shares |
| 1 year | -0.4% | -70.2K shares |
| 3 years | -8.9% | -1.6M shares |
| 5 years | -8.3% | -1.5M shares |
| Available history | -8.3% | -1.5M shares |
RGR has 16M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $10M |
| Q2 2025 | $13.2M |
| Q1 2025 | $3M |
| Q4 2024 | $5.1M |
| Q3 2024 | $9.1M |
| Q2 2024 | $17.1M |
| Q1 2024 | $3.2M |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
RGR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -40.4x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
RGR has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.1 | Overbought |
| Stochastic | 72.3 | Neutral |
RGR's weekly RSI is 70 (overbought) and its Stochastic is 72 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over RGR on valuation relative to its sector.
RGR PE vs Industrials Sector
| Metric | RGR | Sector median | Relative |
|---|---|---|---|
| PE | 49x | 24x | 103% above |
| PE % | 87 | 58 | 29 pts above |
RGR is trading at 49x earnings, a 103% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
RGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.4 | 9% above |
| 20 week MA | $41.0 | 21% above |
| 50 week MA | $39.3 | 26% above |
| 100 week MA | $38.2 | 30% above |
| 200 week MA | $42.9 | 15% above |
RGR has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
RGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.6 | $67.2 | +44% |
| 2021 | $67.2 | $66.4 | -1.2% |
| 2022 | $66.4 | $51.6 | -22% |
| 2023 | $51.6 | $45.5 | -12% |
| 2024 | $45.5 | $34.7 | -24% |
| 2025 | $34.7 | $32.3 | -6.9% |
| 2026 YTD | $32.3 | $49.5 | +53% |
RGR has the edge over CAT on returns for 2026, with the stronger performance.